C. E. Hoffmann

1.8k total citations · 1 hit paper
19 papers, 958 citations indexed

About

C. E. Hoffmann is a scholar working on Molecular Biology, Epidemiology and Organic Chemistry. According to data from OpenAlex, C. E. Hoffmann has authored 19 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Epidemiology and 2 papers in Organic Chemistry. Recurrent topics in C. E. Hoffmann's work include Influenza Virus Research Studies (6 papers), DNA and Nucleic Acid Chemistry (4 papers) and Cancer therapeutics and mechanisms (2 papers). C. E. Hoffmann is often cited by papers focused on Influenza Virus Research Studies (6 papers), DNA and Nucleic Acid Chemistry (4 papers) and Cancer therapeutics and mechanisms (2 papers). C. E. Hoffmann collaborates with scholars based in United States. C. E. Hoffmann's co-authors include E Neumayer, R. F. Haff, J. W. McGahen, R. R. Grunert, W. L. Davies, Jonathan Watts, Terry Wood, Richard A. Goldsby, J. O. Lampen and Philip B. Sweetser and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

C. E. Hoffmann

19 papers receiving 838 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiviral Activity of 1-Adamantanamine (Amantadine)

1964 652 citations W. L. Davies, R. R. Grunert et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. E. Hoffmann United States	10	402	284	195	110	89	19	958
J. W. McGahen United States	9	359 0.9×	268 0.9×	189 1.0×	96 0.9×	81 0.9×	13	892
W. L. Davies United States	6	346 0.9×	228 0.8×	187 1.0×	99 0.9×	80 0.9×	9	819
Terry Wood Canada	11	299 0.7×	274 1.0×	184 0.9×	85 0.8×	69 0.8×	21	906
R. R. Grunert United States	13	561 1.4×	361 1.3×	213 1.1×	148 1.3×	128 1.4×	23	1.3k
R. F. Haff United States	18	550 1.4×	494 1.7×	314 1.6×	172 1.6×	167 1.9×	40	1.6k
Julian J. Jaffe United States	21	303 0.8×	681 2.4×	183 0.9×	171 1.6×	34 0.4×	85	1.4k
Jonathan D. Bloom United States	27	367 0.9×	481 1.7×	573 2.9×	127 1.2×	62 0.7×	50	1.8k
Kazuo Tsuzuki Japan	20	295 0.7×	337 1.2×	259 1.3×	123 1.1×	25 0.3×	44	1.1k
R. M. J. Ings United Kingdom	18	110 0.3×	379 1.3×	86 0.4×	120 1.1×	50 0.6×	39	1.3k
John J. McCormack United States	25	204 0.5×	702 2.5×	352 1.8×	118 1.1×	152 1.7×	80	1.5k

Countries citing papers authored by C. E. Hoffmann

Since Specialization

Citations

This map shows the geographic impact of C. E. Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. E. Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. E. Hoffmann more than expected).

Fields of papers citing papers by C. E. Hoffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. E. Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. E. Hoffmann. The network helps show where C. E. Hoffmann may publish in the future.

Co-authorship network of co-authors of C. E. Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of C. E. Hoffmann. A scholar is included among the top collaborators of C. E. Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. E. Hoffmann. C. E. Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

1.

Hoffmann, C. E.. (2015). Structure, Activity and Mode of Action of Amantadine HCl and Related Compounds. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 27. 233–250. 2 indexed citations

2.

Hoffmann, C. E., et al.. (2010). The production of high quality beef meat - an alternative for milk producers in South Tyrol?. 20(2). 117–126. 1 indexed citations

3.

Hoffmann, C. E.. (1977). DISCUSSION. Annals of the New York Academy of Sciences. 284(1). 289–293. 1 indexed citations

4.

Grunert, R. R. & C. E. Hoffmann. (1977). Sensitivity of Influenza A/New Jersey/8/76 (HswlNl) Virus to AmantadinebulletHCI. The Journal of Infectious Diseases. 136(2). 297–300. 15 indexed citations

5.

Hoffmann, C. E.. (1972). mode of action of bromacil and related uracils. 2 indexed citations

6.

McGahen, J. W., E Neumayer, R. R. Grunert, & C. E. Hoffmann. (1970). INFLUENZA INFECTIONS OF MICE: II. CURATIVE ACTIVITY OF α‐METHYL‐1‐ADAMANTANEMETHYLAMINE HCl (RIMANTADINE HCl). Annals of the New York Academy of Sciences. 173(1). 557–581. 20 indexed citations

7.

McGahen, J. W. & C. E. Hoffmann. (1968). Influenza Infections of Mice. I. Curative Activity of Amantadine HCI. Experimental Biology and Medicine. 129(3). 678–681. 18 indexed citations

8.

Hoffmann, C. E., et al.. (1968). Production of antibody in amantadine hydrochloride-treated mice. Virology. 35(4). 622–624. 3 indexed citations

9.

McGahen, J. W. & C. E. Hoffmann. (1966). Absence of Mutagenic Effects of 3- and 6-Alkyl-5-bromouracil Herbicides on a Bacteriophage. Nature. 209(5029). 1241–1242. 3 indexed citations

10.

Davies, W. L., R. R. Grunert, & C. E. Hoffmann. (1965). Influenza Virus Growth and Antibody Response in Amantadine-Treated Mice. The Journal of Immunology. 95(6). 1090–1094. 20 indexed citations

11.

Neumayer, E, R. F. Haff, & C. E. Hoffmann. (1965). Antiviral Activity of Amantadine Hydrochloride in Tissue Culture and in ovo.. Experimental Biology and Medicine. 119(2). 393–396. 46 indexed citations

12.

Hoffmann, C. E., E Neumayer, R. F. Haff, & Richard A. Goldsby. (1965). Mode of Action of the Antiviral Activity of Amantadine in Tissue Culture. Journal of Bacteriology. 90(3). 623–628. 86 indexed citations

13.

Davies, W. L., R. R. Grunert, R. F. Haff, et al.. (1964). Antiviral Activity of 1-Adamantanamine (Amantadine). Science. 144(3620). 862–863. 652 indexed citations breakdown →

14.

Davies, W. L., R. R. Grunert, R. F. Haff, et al.. (1964). Antiviral Activity of l-Adamantanamine (Amantadine).. 44. 21 indexed citations

15.

Hoffmann, C. E., J. W. McGahen, & Philip B. Sweetser. (1964). Effect of Substituted Uracil Herbicides on Photosynthesis. Nature. 202(4932). 577–578. 9 indexed citations

16.

McGahen, J. W. & C. E. Hoffmann. (1963). Action of 5-Bromo-3-sec-butyl-6-methyluracil on Escherichia coli 15T. Nature. 200(4906). 571–572. 5 indexed citations

17.

McGahen, J. W. & C. E. Hoffmann. (1963). Action of 5-Bromo-3-sec-Butyl-6-Methyluracil as Regards Replacement of Thymine in Mouse DNA. Nature. 199(4895). 810–811. 7 indexed citations

18.

Patterson, E. L., Jack V. Pierce, E. L. R. Stokstad, et al.. (1954). The Isolation of Protogen. Journal of the American Chemical Society. 76(7). 1823–1826. 19 indexed citations

19.

Hoffmann, C. E. & J. O. Lampen. (1952). PRODUCTS OF DESOXYRIBOSE DEGRADATION BY ESCHERICHIA COLI. Journal of Biological Chemistry. 198(2). 885–893. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact